Future Tech II Acquisition Corp.
Status: Live Deal
U=S+W
W=S@11.5
| IPO Proceeds, $M | $115.00M |
|---|---|
| IPO Date | Feb 16, 2022 |
| CEO | Ray Chen |
| Left Lead | EF Hutton |
| IPO Cash in Trust | 102.0% |
| SPAC Tenor | 12 + 3 + 3 + 6 + 9 |
| IPO Sector |
Technology
Technology (excluding China) |
| IPO Geography | Global |
| Target Company | Longevity Biomedical |
| Deal Announced | Sep 20, 2024 |
| Deal Size, $M | TBD |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | Nov 18, 2024 |
FTII
FTIIU
FTIIW
| Price | $11.03 |
|---|---|
| Last closing price | $10.96 |
| H/L, today | $10.96 / $11.03 |
| H/L, 52-week | $10.08 / $12.12 |
| Volume, today | 4,813 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Future Tech II Acquisition Corp.:
- Structure and cap table
- 5 directors & officers
- 22 filings and events
- 4 underwriters
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Ray Chen | CEO, CFO and Director | |
| Yuquan Wang | 50 | Director |
| Neil Bush | 66 | Director |
| Jeffrey Moseley | 67 | Director |
| Jonathan McKeage | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| EF Hutton | BR | 945,000 | units |
| Tiger Brokers | 6,050,000 | ||
| US Tiger Securities | 3,000,000 | ||
| Joseph Gunnar | 5,000 | ||
| 10,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.00 | % |
Sign in to view more advisor data.